Expanded Studies on the SCAPIS Stockholm Reexamination Cohort
Recruiting
Observational Study
Coronary Artery Disease
Arterial Stiffness, Blood Pressure
AORTIC VALVE DISEASES
Mitral Valve Stenosis and/or Insufficiency
Heart Failure
Pulmonary Disease, Chronic Obstructive (COPD)
Steatohepatitis
Inflammation Biomarkers
Lipid Profile
Oral Microbiota
MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease
Metabolic Associated-dysfunction Steatohepatitis (MASH)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 56 – 74
- Sex
- Any
- Study type
- Observational
- Participants needed
- 1,400 (estimated)
- Sponsor
- Danderyd Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The Swedish CArdioPulmonary bioImage Study (SCAPIS) is a unique, large-scale national research initiative involving 30,000 randomly selected individuals aged 50-64, recruited between 2014 and 2018. The study is a collaborative effort among six university hospitals across Sweden. A follow-up study, SCAPIS 2, is conducted for half of the original participants. In Stockholm, 2,500 individuals will be…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria: Subjects already included in the main / general SCAPIS reexamination study in Stockholm.
Exclusion Criteria: Inability to provide consent.
Contacts